Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood

被引:28
作者
Xiao, JJ
Byrd, J
Marcucci, G
Grever, M
Chan, KK [1 ]
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1002/rcm.976
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Four glutathione (GSH) conjugates and two thiols were detected when depsipeptide FK228, formerly FR901228, a naturally occurring potent histone deacetylase (HDAC) inhibitor, was incubated in rat or human plasma in the presence of GSH. Their structures were elucidated by the high-performance liquid chromatography/electrospray ionization multi-stage mass spectrometry (HPLC/ESI-MSn) technique, and in some cases confirmed by accurate mass measurement. These products were also detected in rat and human blood homogenates following their incubation with FK228, but were not detected in GSH solution alone. A possible scheme for its formation is proposed. One of the thiols has recently been found to be more active as a histone deacetylase inhibitor than the parent compound. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:757 / 766
页数:10
相关论文
共 50 条
[21]   Phase I trial of the histone deacetylase inhibitor depsipeptide (FR901228) in fludarabine refractory chronic lymphocytic leukemia. [J].
Bruner, RJ ;
Marcucci, G ;
Binkley, P ;
Xiao, J ;
Chan, K ;
Parthun, M ;
Davis, M ;
Fischer, B ;
Shank, R ;
Moran, M ;
Grever, M ;
Byrd, JC .
BLOOD, 2002, 100 (11) :385A-385A
[22]   Adenovirus transgene expression is enhanced in normal and malignant hematopoietic cells by pretreatment with the histone deacetylase inhibitor FR901228 (depsipeptide). [J].
Rao, VK ;
Kitazono, M ;
Robey, R ;
Aikou, T ;
Bates, SE ;
Fojo, T ;
Goldsmith, ME .
BLOOD, 2001, 98 (11) :424A-424A
[23]   Anti-tumor activity of histone deacetylase inhibitor FK228 (depsipeptide) for human prostate cancer cells [J].
Chen, W. C. ;
Lai, M. T. ;
Tsai, F. J. ;
Lin, T. Y. ;
Yang, C. C. .
EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) :82-82
[24]   Potential value of the histone deacetylase inhibitor depsipeptide (FR901228) in the treatment of peripheral and cutaneous T-cell lymphoma. [J].
Piekarz, R ;
Robey, R ;
Sandor, V ;
Fojo, AT ;
Bakke, S ;
Wilson, W ;
Kingma, D ;
Turner, M ;
Tucker, E ;
Bates, SE .
CLINICAL CANCER RESEARCH, 2001, 7 (11) :3726S-3726S
[25]   Marker genes to predict sensitivity to FK228, a histone deacetylase inhibitor [J].
Sasakawa, Y ;
Naoe, Y ;
Sogo, N ;
Inoue, T ;
Sasakawa, T ;
Matsuo, M ;
Manda, T ;
Mutoh, S .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (04) :603-616
[26]   Total Synthesis of the Bicyclic Depsipeptide HDAC Inhibitors Spiruchostatins A and B, 5"-epi-Spiruchostatin B, FK228 (FR901228) and Preliminary Evaluation of Their Biological Activity [J].
Narita, Koichi ;
Kikuchi, Takuya ;
Watanabe, Kazuhiro ;
Takizawa, Toshiya ;
Oguchi, Takamasa ;
Kudo, Kyosuke ;
Matsuhara, Keisuke ;
Abe, Hideki ;
Yamori, Takao ;
Yoshida, Minoru ;
Katoh, Tadashi .
CHEMISTRY-A EUROPEAN JOURNAL, 2009, 15 (42) :11174-11186
[27]   Histone deacetylase inhibitor FK228 is a potent inducer of human fetal haemoglobin [J].
Cao, Hua ;
Stamatoyannopoulos, George .
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (12) :981-983
[28]   Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176) [J].
Robey, RW ;
Zhan, ZR ;
Piekarz, RL ;
Kayastha, GL ;
Fojo, T ;
Bates, SE .
CLINICAL CANCER RESEARCH, 2006, 12 (05) :1547-1555
[29]   Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy [J].
Pojani, Eftiola ;
Barlocco, Daniela .
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (07) :1290-1303
[30]   Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228 [J].
Kitazono, M ;
Goldsmith, ME ;
Aikou, T ;
Bates, S ;
Fojo, T .
CANCER RESEARCH, 2001, 61 (17) :6328-6330